InMed Pharmaceuticals
7 hedge funds and large institutions have $28.5K invested in InMed Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$25.2K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$1.3K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $25.2K | 7,762 | +1,656 | +27% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $1.3K | 400 | +400 | New |
|
|
BCV
3
Banque Cantonale Vaudoise
Lausanne,
Switzerland
| $1K | 6 | – | – |
|
|
SS
4
SBI Securities
Tokyo,
Japan
| $975 | 300 | – | – |
|
|
AWM
5
AllSquare Wealth Management
Albany,
New York
| $3 | 1 | – | – |
|
|
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $3 | 1 | – | – |
|
7
Bessemer Group
Woodbridge,
New Jersey
| $0 | 1 | +1 | New |
|